Organic compounds

Details for Australian Patent Application No. 2007234968 (hide)

Owner Novartis AG

Inventors Ksander, Gary Michael; Adams, Christopher; Papillon, Julien

Agent Davies Collison Cave

Pub. Number AU-A-2007234968

PCT Pub. Number WO2007/117982

Priority 60/787,104 29.03.06 US

Filing date 27 March 2007

Wipo publication date 18 October 2007

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4725 (2006.01)

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

11 September 2008 PCT application entered the National Phase

  PCT publication WO2007/117982 Priority application(s): WO2007/117982

12 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007234982-Methods for treating conditions associated with MASP-2 dependent complement activation

2007234967-Selective hydroxamate based MMP inhibitors